Coming Soon

Public Funding for Helix Research and Enterprise Limited

Registration Number NI665083

« Company Overview

Biomedical Catalyst Neurotechnology Accelerator

245,450
2023-05-01 to 2023-10-31
Collaborative R&D
no public description

ICURe Delivery 2022-2025 (non competed)

7,000,000
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

7,000,000
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

7,369,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

ICURe Delivery 2022-2025 (non competed)

9,829,740
2022-04-01 to 2025-03-31
Collaborative R&D

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.